| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.068 | 0.04 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.06 | 0.04 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.078 | 0.05 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.05 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.05 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | -0.066 | 0.05 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.05 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | -0.33 | 0.05 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | -0.27 | 0.05 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.05 |